Cargando…

Metacognitions in Patients With Frequent Mental Disorders After Diagnosis of Pulmonary Arterial Hypertension

BACKGROUND: The prevalence of mental disorders, particularly adjustment disorder (AD), major depressive disorder (MDD) and panic disorder (PD) is increased in patients with pulmonary arterial hypertension (PAH). However, it is unclear which pathogenic mechanisms determine their development and could...

Descripción completa

Detalles Bibliográficos
Autores principales: Caldarone, Flora, Gebhardt, Philippa, Hoeper, Marius M., Olsson, Karen M., Fuge, Jan, Park, Da-Hee, Meltendorf, Tanja, Kamp, Jan C., Stapel, Britta, Richter, Manuel J., Gall, Henning, Ghofrani, Hossein A., Kahl, Kai G., Heitland, Ivo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046848/
https://www.ncbi.nlm.nih.gov/pubmed/35492699
http://dx.doi.org/10.3389/fpsyt.2022.812812
_version_ 1784695603910934528
author Caldarone, Flora
Gebhardt, Philippa
Hoeper, Marius M.
Olsson, Karen M.
Fuge, Jan
Park, Da-Hee
Meltendorf, Tanja
Kamp, Jan C.
Stapel, Britta
Richter, Manuel J.
Gall, Henning
Ghofrani, Hossein A.
Kahl, Kai G.
Heitland, Ivo
author_facet Caldarone, Flora
Gebhardt, Philippa
Hoeper, Marius M.
Olsson, Karen M.
Fuge, Jan
Park, Da-Hee
Meltendorf, Tanja
Kamp, Jan C.
Stapel, Britta
Richter, Manuel J.
Gall, Henning
Ghofrani, Hossein A.
Kahl, Kai G.
Heitland, Ivo
author_sort Caldarone, Flora
collection PubMed
description BACKGROUND: The prevalence of mental disorders, particularly adjustment disorder (AD), major depressive disorder (MDD) and panic disorder (PD) is increased in patients with pulmonary arterial hypertension (PAH). However, it is unclear which pathogenic mechanisms determine their development and could therefore be targeted in prevention or therapeutic interventions. Here, we assessed metacognitions in a sample of PAH patients with and without MDD and PD. Moreover, we reconstructed the course of mental illnesses following the PAH diagnosis. METHODS: Two hundred seventeen PAH patients were included in this cross-sectional study. The prevalence of AD was assessed retrospectively using DSM-V criteria. Current mental disorders were assessed using the structured clinical interview for DSM-V. Additionally, metacognitive beliefs and processes were assessed using established questionnaires (MCQ-30, AnTI). RESULTS: Patients with an AD consecutive to the PAH diagnosis more frequently developed MDD (37.5 vs. 13.9%, p < 0.001) and PD (26.3 vs. 8.8%, p = 0.001) later on compared to PAH patients without a former AD. Moreover, patients with current MDD/PD displayed more dysfunctional metacognitions than those without current MDD/PD (p < 0.001). Patients with current MDD/PD in the context of former AD had more dysfunctional metacognitive worries and beliefs compared to patients with current MDD/PD without former AD (p = 0.009). CONCLUSION: Our results suggest that in the context of PAH, dysfunctional metacognitions are associated with MDD and PD. Therefore, a metacognitive approach to treat and prevent those mental illnesses seems promising and should be investigated in future studies.
format Online
Article
Text
id pubmed-9046848
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90468482022-04-29 Metacognitions in Patients With Frequent Mental Disorders After Diagnosis of Pulmonary Arterial Hypertension Caldarone, Flora Gebhardt, Philippa Hoeper, Marius M. Olsson, Karen M. Fuge, Jan Park, Da-Hee Meltendorf, Tanja Kamp, Jan C. Stapel, Britta Richter, Manuel J. Gall, Henning Ghofrani, Hossein A. Kahl, Kai G. Heitland, Ivo Front Psychiatry Psychiatry BACKGROUND: The prevalence of mental disorders, particularly adjustment disorder (AD), major depressive disorder (MDD) and panic disorder (PD) is increased in patients with pulmonary arterial hypertension (PAH). However, it is unclear which pathogenic mechanisms determine their development and could therefore be targeted in prevention or therapeutic interventions. Here, we assessed metacognitions in a sample of PAH patients with and without MDD and PD. Moreover, we reconstructed the course of mental illnesses following the PAH diagnosis. METHODS: Two hundred seventeen PAH patients were included in this cross-sectional study. The prevalence of AD was assessed retrospectively using DSM-V criteria. Current mental disorders were assessed using the structured clinical interview for DSM-V. Additionally, metacognitive beliefs and processes were assessed using established questionnaires (MCQ-30, AnTI). RESULTS: Patients with an AD consecutive to the PAH diagnosis more frequently developed MDD (37.5 vs. 13.9%, p < 0.001) and PD (26.3 vs. 8.8%, p = 0.001) later on compared to PAH patients without a former AD. Moreover, patients with current MDD/PD displayed more dysfunctional metacognitions than those without current MDD/PD (p < 0.001). Patients with current MDD/PD in the context of former AD had more dysfunctional metacognitive worries and beliefs compared to patients with current MDD/PD without former AD (p = 0.009). CONCLUSION: Our results suggest that in the context of PAH, dysfunctional metacognitions are associated with MDD and PD. Therefore, a metacognitive approach to treat and prevent those mental illnesses seems promising and should be investigated in future studies. Frontiers Media S.A. 2022-04-14 /pmc/articles/PMC9046848/ /pubmed/35492699 http://dx.doi.org/10.3389/fpsyt.2022.812812 Text en Copyright © 2022 Caldarone, Gebhardt, Hoeper, Olsson, Fuge, Park, Meltendorf, Kamp, Stapel, Richter, Gall, Ghofrani, Kahl and Heitland. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Caldarone, Flora
Gebhardt, Philippa
Hoeper, Marius M.
Olsson, Karen M.
Fuge, Jan
Park, Da-Hee
Meltendorf, Tanja
Kamp, Jan C.
Stapel, Britta
Richter, Manuel J.
Gall, Henning
Ghofrani, Hossein A.
Kahl, Kai G.
Heitland, Ivo
Metacognitions in Patients With Frequent Mental Disorders After Diagnosis of Pulmonary Arterial Hypertension
title Metacognitions in Patients With Frequent Mental Disorders After Diagnosis of Pulmonary Arterial Hypertension
title_full Metacognitions in Patients With Frequent Mental Disorders After Diagnosis of Pulmonary Arterial Hypertension
title_fullStr Metacognitions in Patients With Frequent Mental Disorders After Diagnosis of Pulmonary Arterial Hypertension
title_full_unstemmed Metacognitions in Patients With Frequent Mental Disorders After Diagnosis of Pulmonary Arterial Hypertension
title_short Metacognitions in Patients With Frequent Mental Disorders After Diagnosis of Pulmonary Arterial Hypertension
title_sort metacognitions in patients with frequent mental disorders after diagnosis of pulmonary arterial hypertension
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046848/
https://www.ncbi.nlm.nih.gov/pubmed/35492699
http://dx.doi.org/10.3389/fpsyt.2022.812812
work_keys_str_mv AT caldaroneflora metacognitionsinpatientswithfrequentmentaldisordersafterdiagnosisofpulmonaryarterialhypertension
AT gebhardtphilippa metacognitionsinpatientswithfrequentmentaldisordersafterdiagnosisofpulmonaryarterialhypertension
AT hoepermariusm metacognitionsinpatientswithfrequentmentaldisordersafterdiagnosisofpulmonaryarterialhypertension
AT olssonkarenm metacognitionsinpatientswithfrequentmentaldisordersafterdiagnosisofpulmonaryarterialhypertension
AT fugejan metacognitionsinpatientswithfrequentmentaldisordersafterdiagnosisofpulmonaryarterialhypertension
AT parkdahee metacognitionsinpatientswithfrequentmentaldisordersafterdiagnosisofpulmonaryarterialhypertension
AT meltendorftanja metacognitionsinpatientswithfrequentmentaldisordersafterdiagnosisofpulmonaryarterialhypertension
AT kampjanc metacognitionsinpatientswithfrequentmentaldisordersafterdiagnosisofpulmonaryarterialhypertension
AT stapelbritta metacognitionsinpatientswithfrequentmentaldisordersafterdiagnosisofpulmonaryarterialhypertension
AT richtermanuelj metacognitionsinpatientswithfrequentmentaldisordersafterdiagnosisofpulmonaryarterialhypertension
AT gallhenning metacognitionsinpatientswithfrequentmentaldisordersafterdiagnosisofpulmonaryarterialhypertension
AT ghofranihosseina metacognitionsinpatientswithfrequentmentaldisordersafterdiagnosisofpulmonaryarterialhypertension
AT kahlkaig metacognitionsinpatientswithfrequentmentaldisordersafterdiagnosisofpulmonaryarterialhypertension
AT heitlandivo metacognitionsinpatientswithfrequentmentaldisordersafterdiagnosisofpulmonaryarterialhypertension